Solute carrier family 2 member 1 (SLC2A1), commonly referred to as glucose transporter protein type 1, has been consistently associated with the occurrence and prognosis of pancreatic cancer in numerous studies 35-37. This evidence concerns the gene SLC1A2 and pancreatic neoplasm.